Abstract
Prostacyclin is primarily derived from vascular endothelium and has traditionally been regarded as an important regulator of haemostasis due to its potent anti-platelet and vasodilator activity [1]. However, prostacyclin has additional biological activity mediated by receptors located in both the peripheral and central nervous system (CNS), and it is recent developments in the study of these neuronal prostacyclin receptors (IP-receptors) which form the basis of the following review. These are early days still in our understanding of the neuronal function of prostacyclin; I hope therefore that this review will set the scene for what is a rapidly developing and exciting area of research. To date only one IP-receptor has been isolated and cloned [2], and this represents the classical IP-receptor present in platelets. While evidence will be presented for the existence of subtypes of the IP-receptor, to date none of these have been cloned. Therefore to avoid the use of possibly inappropriate nomenclature, I shall refer to the subtypes with respect to their primary location, for example enteric IP-receptors or neuronal IP-receptors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. Moncada: Br. J. Pharmacol 76, 3–31 (1982).
M. Hirata, F. Ushikubi and S. Narumiya: J. Lipid Mediators Cell Signal. 12, 393–404 (1995).
P. Needleman, J. Turk, B.A. Jakschik, A.R. Morison and J.B. Lefkowith: Annu. Rev. Biochem. 55, 69–102 (1986).
R.A. Coleman, W.L. Smith and S. Narumiya: Pharmacol. Rev. 46, 205–229 (1994).
L. Wang and L. Chen: Biochem. Biophys. Res. Commun. 226, 631–637 (1996).
T. Tanabe and V. Ullrich: J. Lipid Mediators Cell Signal. 12, 243–255 (1995).
Y.J. Dong, R.L. Jones and N.H. Wilson: Br. J. Pharmacol. 87, 97–107 (1986).
R.A. Lawrence, R.L. Jones and N.H. Wilson: Br. J. Pharmacol. 105, 271–278 (1992).
Y. Kawai and T. Ohhashi: Br. J. Pharmacol. 112, 635–639 (1994).
R.L. Jones, N.H. Wilson, C.G. Marr, G. Muir and R.A. Armstrong: J. Lipid Mediators Cell Signal. 6, 405–410 (1993).
N.A. Meanwell, J.L. Romine and S.M. Seiler: Drugs of the Future 19, 361–385 (1994).
T. Namba, H. Oida, Y. Sugimoto, A. Kakizuka, M. Negishi, A. Ichikawa and S. Narumiya: J. Biol. Chem. 269, 9986–9992 (1994).
Y Boie, T.H. Rushmore, A. Darmon-Goodwin, R. Grygorczyk, D.M. Slipetz, K.M. Metters and M. Abramovitz: J.Biol. Chem. 269, 12173–12178 (1994).
M. Katsuyama, Y Sugimoto, T. Namba, A. Irie, M. Negishi, S. Narumiya and A. Ichikawa: FEBS Lett. 344, 74–78 (1994).
O. Nakagawa, I.Tanaka, T. Usui, M. Harada, Y Sasaki, H. Itoh, T. Yoshimasa, T. Namba, S. Narumiya and K. Nakao: Circ. 90, 1643–1647 (1994).
Y Sasaki, T. Usui, I.Tanaka, O. Nakagawa, T. Sando, T. Takahashi, T. Namba, S. Narumiya and K. Nakao: Biochim. Biophys. Acta 1224, 601–605 (1994).
K.L. Pierce, D.W. Gil, D.F. Woodward and J.W. Regan: Trends Pharmacol. Sci. 16, 253–256 (1995).
M. Negishi, Y Sugimoto and A. Ichikawa: Biochim. Biophys. Acta 1259, 109–120 (1995).
F. Ushikubi, M. Hirata and S. Narumiya: J.Lipid Mediators Cell Signal. 12, 343–359 (1995).
T. Ishikawa, Y.Tamai, J.M. Rochelle, M. Hirata, T. Namba, Y Sugimoto, A. Ichikawa, S. Narumiya, M.M. Taketo and M.F. Seldin: Genomics 32, 285–288 (1996).
E.M. Smyth, P.V. Nestor and G.A. Fitzgerald: J.Biol. Chem. 271, 33698–33704 (1996).
P.J. Leigh and J. MacDermot: Br. J.Pharmacol. 85, 237–247 (1985).
T. Kenakin: Pharmacol. Rev. 48, 413–463 (1996).
H. Wise and R.L. Jones: Trends Pharmacol. Sci. 17, 17–21 (1996).
R. Murray, E. Shipp and G.A. Fitzgerald: J.Biol. Chem. 265, 21670–21675 (1990).
T. Sawai, M. Negishi, N. Nishigaki, T. Ohno and A. Ichikawa: J.Biol. Chem. 268, 1995–2000 (1993).
C. Cazevieille, A. Muller, F. Meynier, N. Dutrait and C. Bonne: Neurochem. Int. 24, 395–398 (1994).
C. Cazevieille, A. Muller and C. Bonne: Neurosci. Lett. 160, 106–108 (1993).
J. Aubert, G Ailhaud and R. Negrel: FEBS Lett. 397, 117–121 (1996).
R.A. Armstrong, R.A. Lawrence, R.L. Jones, N.H. Wilson and A. Collier: Br. J.Pharmacol. 97, 657–668 (1989).
A. Corsini, G.C. Folco, R. Fumagalli, S. Nicosia, M.A. Noe and D. Oliva: Br. J.Pharmacol. 90, 255–261 (1987).
J.E. Merritt, T.J. Hallam, A.M. Brown, I. Boyfield, D.G. Cooper, D.M.B. Hickey, A.A. Jaxa-Chamiec, A.J. Kaumann, M. Keen, E. Kelly, U. Kozlowski and T.J. Rink: Br. J. Pharmacol. 102, 251–259 (1991).
R.L. Hébert, L. Regnier and L.N. Peterson: Am. J. Physiol. 268, F145–F154 (1995).
E. Ragazzi, A. Chinellato, Ü. Lille, M. Lopp, M.G. Doni and G. Fassina: Gen. Pharmacol. 26, 703–709 (1995).
H. Wise, Y. Qian and R.L. Jones: Eur. J. Pharmacol. 278, 265–269 (1995).
H. Takechi, K. Matsumura, Y. Watanabe, K. Kato, R. Noyori and M. Suzuki: J. Biol. Chem. 271, 5901–5906 (1996).
T.P. Kenakin: J. Pharmacological Methods 13, 281–308 (1985).
B.J.R. Whittle, S. Moncada, K. Mullane and J.R. Vane: Prostaglandins 25, 205–223 (1983).
J.M. Hall and P.G. Strange: Bioscience Reports 4, 941–948 (1984).
P.J. Leigh, W.A. Cramp and I MacDermot: J. Biol. Chem. 259, 12431–12436 (1984).
S. Seiler, C.L. Brassard, A.J. Arnold, N.A. Meanwell, J.S. Fleming and S.L. Keely Jr: J. Pharm. Exp. Ther. 255, 1021–1026 (1990).
S.M. Seiler, C.L. Brassard, M.E. Federici, J.O. Buchanan, G.B. Zavoico, J.S. Fleming and N.A. Meanwell: Thromb. Res. 74, 115–123 (1994).
N.A.Meanwell, J.L. Romine, MJ. Rosenfeld, S.W. Martin, A.K.Trehan, J.J.K. Wright, M.F. Malley, J.Z. Gougoutas, C.L. Brassard, J.O. Buchanan, M.E. Federici, J.S. Fleming, M. Gamberdella, K.S. Hart, G.B. Zavoico and S.M. Seiler: J. Med. Chem. 36, 3884–3903 (1993).
K. Matsumura, Y. Watanabe, H. Onoe and Y. Watanabe: Neurosci. 65, 493–503 (1995).
H.J. Exner and E. Schlicker: Naunyn-Schmiedeberg’s Arch. Pharmacol. 351, 46–52 (1995).
H. Oida, T. Namba, Y Sugimoto, F. Ushikubi, H. Ohishi, A. Ichikawa and S. Naru-miya: Br. J. Pharmacol. 116, 2828–2837 (1995).
K.R. Bley, D.G. Blissard, S.M. Amagasu and R.M. Eglen: Prostaglandins Leuk. Essen. Fatty Acids 55, S1, pl59 (1996).
M. Suzuki, K. Kato, R. Noyori, Y Watanabe, K. Takechi, K. Matsumura and B. Lång-ström: Angew. Chem. Int. Ed. Engl. 35, 334–336 (1996).
A.S. Milton: Ann. N Y Acad. Sci. 604, 392–410 (1990).
K. Yamashita, Y Kataoka, M. Nakashima, Y. Yamashita, H. Tanabe, H. Araki, M. Niwa and K.Taniyama: Jpn. J. Pharmacol. 71, 351–355 (1996).
T. Minagawa, K. Sakanaka, S. Inaba, Y Sai, I.Tamai, T. Suwa and A. Tsuji: J. Pharm. Pharmacol. 48, 1016–1022 (1996).
M. Tanaka, C. Kojima, M. Muramatsu and H. Tanabe: Arzneimittel-Forschung 45, 967–970 (1995).
K. Hoshi and Y Mizushima: Prostaglandins 40, 155–164 (1990).
E. Kelly, M. Keen, P. Nobbs and J. MacDermot: Br. J. Pharmacol. 99, 309–316 (1990).
H. Wise and B.S. Chow, in: Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research (H. Sinzinger, J.R. Vane, B. Samuelsson, R. Paoletti, P.W. Ram-well and P.Y.-K. Wong, eds.), Plenum Press, New York (in press).
R.A. Ross, B.A. Spengler and J.L. Biedler: J.Natl. Cancer Inst. 71, 741–749 (1983).
G.D. Kim, F.J. Adie and G. Milligan: Eur. J.Biochem. 219, 135–143 (1994).
G.D. Kim, I.C. Carr and G. Milligan: Biochem. J. 308, 275–281 (1995).
A. Krane, J. MacDermotand M. Keen: Biochem. Pharmacol. 47, 953–959 (1994).
A. Krane and M. Keen: Br. J.Pharmacol. 115, 137P (1995).
A. Krane and M. Keen: Br. J.Pharmacol. 115, 138P (1995).
M. Keen and A. Krane: Br. I Pharmacol 117, 72P (1996).
R.J. Williams and E. Kelly: Eur. J.Pharmacol. 268, 177–186 (1994).
D. Pearce and M. Keen: Br. I Pharmacol 116, 19P (1995).
H. Ammer and R. Schulz: Mol Pharmacol 43, 556–563 (1993).
H. Ammer and R. Schulz: Brain Res. 707, 235–244 (1996).
J. Luty, M. Hepworth, E. Kelly and G. Henderson: Br. J. Pharmacol 116, 355P (1995).
N. Inagaki and H. Wada: Glia 11, 102–109 (1995).
J. Kitanaka, H. Hashimoto, M. Gotoh, K. Kondo, K. Sakata, Y. Hirasawa, M. Sawada, A. Suzumura, T. Marunouchi, T. Matsuda and A. Baba: Brain Res. 707, 282–287 (1996).
S. Murphy, J. Jeremy, B. Pearce and P. Dandona: Neurosci. Letts. 61, 61–65 (1985).
S.A. Moore, P.H. Figard, A.A. Spector and M.N. Hart: Ann. N Y Acad. Sci. 604, 471–473 (1990).
K.U. Malik and E. Sehic: Ann. N Y Acad. Sci. 640, 222–236 (1990).
R. Gonzales, C.D. Sherbourne, M.E. Goldyne and J.D. Levine: J. Neurochem. 57, 1145–1150 (1991).
K. Yamagata, K.I. Andreasson, W.E. Kaufmann, C.A. Barnes and P.F. Worley: Neuron 11, 371–386 (1993).
C. Cao, K. Matsumura, K. Yamagata and Y Watanabe: Brain Res. 697, 187–196 (1995).
J. de Belleroche, J. Adams and Y. Collaço-Moraes: Prostaglandins Leuk. Essen. Fatty Acids 55, S1, p32 (1996).
Y Collaço-Moraes, B. Aspey, M. Harrison and J. de Belleroche: J. Cerebral Blood Flow and Metabolism 76, 1366–1372 (1996).
C. Cao, K. Matsumura, K. Yamagata and Y. Watanabe: Brain Res. 733, 263–272 (1996).
B.L. Fiebich, K. Biber, K. Lieb, D. van Calker, M. Berger, J. Bauer and P.J. Gebicke-Haerter: Glia 18, 152–160 (1996).
M. Kawasaki, Y Yoshihara, M. Yamaji and Y Watanabe: Mol Brain Res. 19, 39–46 (1993).
G. Hertting and A. Seregi: Ann. N Y Acad. Sci. 604, 84–99 (1990).
P.C. Huttemeier, Y Kamiyama, M. Su, W.D. Watkins and H. Benveniste: Prostaglandins 45, 177–187 (1993).
C.W. Leffler and H. Parfenova: Am. J. Physiol 41, H418–H424 (1997).
G. Hertting and A. Seregi, in: Arachidonic Acid Metabolism in the Nervous System (A.I. Barkai and N.G. Bazan, eds.), New York Academy of Science, New York (1989), pp. 84–99.
R.P. White: Ann. N Y Acad. Sci. 604, 131–145 (1990).
E. Shohami, Y. Shapira, G. Yadid, S. Cotev and G. Feuerstein: Ann. N Y Acad. Sci. 604, 485–487 (1990).
B.M. Djurič ić, V.S. Kostic and B.B. Mrš ulja: Ann. N Y Acad. Sci. 604, 435–437 (1990).
J. A. Yergey, N. Salem Jr, J.W. Karanian, M. Linnoila and M.P. Heyes: Ann. N Y Acad. Sci. 604, 497–499 (1990).
J.C.S. Breitner: Annu. Rev. Med. 47, 401–411 (1996).
J. O’Grady, S. Warrington, M.J. Moti, S. Bunting, R.J. Flower, A.S.E. Fowle, E.A. Higgs and S. Moncada, in: Prostacyclin (J.R. Vane and S. Bergström, eds.), Raven Press, New York (1979), pp. 409–417.
T. Frieling, C. Rupprecht, G. Dobreva, D. Häussinger and M. Schemann: Pflugers Archiv. 431, 212–220 (1996).
R.M. Gaion and M. Trento: Br. J. Pharmacol. 80, 279–286 (1983).
R.L. Jones and R.A. Lawrence: Regul Pept. S1, S83 (1992).
Y. Qian and R.L. Jones: Br. J. Pharmacol 115, 163–171 (1995).
R.L. Jones, Y. Qian, F.S.F.Tam, K. Chan, J.K.S. Ho and J.-P. Bourreau: Neuronal stimulant actions of prostacyclin and its novel mimetics, in: Eicosanoids and Other Bio-active Lipids in Cancer, Inflammation and Radiation Injury 3 (K.V. Honn, R.L. Jones, L.J. Marnette, S. Nigam and P.Y.-K. Wong, eds.), Plenum Press, New York (1997), 211–217.
H. Wise: Prostaglandins Leuk. Essen. Fatty Acids 54, 351–360 (1996).
R.A. Armstrong, R.L. Jones, J. MacDermot and N.H. Wilson: Br. J. Pharmacol. 87, 543–551 (1986).
R.L. Jones: Br. J. Pharmacol. 108, 16P (1993).
A.M. McKay and N.L. Poyser: Br. J. Pharmacol. 116, 2679–2684 (1995).
F.S.F. Tarn, K. Chan, J.-P. Bourreau and R.L. Jones: Br. J. Pharmacol, (in press).
G Molderings, B. Malinowska and E. Schlicker: Br. J. Pharmacol. 107, 352–355 (1992).
G.J. Molderings, E. Colling, J. Likungu, J. Jakschik and M. Göthert: Br. J. Pharmacol. 111, 733–738 (1994).
B. Malinowska, G. Godlewski, W. Buczko and E. Schlicker: Eur. J. Pharmacol. 259, 315–319 (1994).
R. Uda, S. Horiguchi, S. Ito, M. Hyodo and O. Hayaishi: Brain Res. 510, 26–32 (1990).
S.H. Ferreira, M. Nakamura and M.S.A. Castro: Prostaglandins 16, 31–37 (1978).
Y.O. Taiwo, L. Bjerknes, E.J. Goetzl and J.D. Levine: Neurosci. 32, 577–580 (1989).
N.S. Doherty, T.H. Beaver, K.Y. Chan, J.E. Coutant and G.L. Westrich: Br. J. Pharmacol. 91, 39–47 (1987).
K. Tanaka, T. Shimotori, S. Makino, M. Eguchi, K. Asaoka, R. Kitamura and C. Yos-hida: J. Pharmacobio-Dyn. 15, 641–647 (1992).
M. Katori, Y. Hori, Y. Uchida, K. Tanaka and Y. Harada: Adv. Exp. Med. Biol. 198, 393–398 (1986).
S.H. Ferreira and M. Nakamura: Prostaglandins 18, 191–200 (1979).
S.H. Ferreira and M. Nakamura: Prostaglandins 18, 201–208 (1979).
G.L. Birrell and D.S. McQueen: Brain Res. 611, 103–107 (1993).
C.M. Hingtgen and M.R. Vasko: Brain Res. 655, 51–60 (1994).
T. Minami, I. Nishihara, R. Uda, S. Ito, M. Hyodo and O. Hayaishi: Br. J. Pharmacol. 112, 735–740 (1994).
Y.O. Taiwo and J.D. Levine: Brain Res. 458, 402–406 (1988).
Y.O. Taiwo and J.D. Levine: Brain Res. 492, 397–399 (1989).
A. Dray: News Physiol. Sci. 11, 288–292 (1996).
K. Matsumura, Y Watanabe, H. Onoe, S. Tanaka, T. Shiraki and S. Kobayashi: Brain Res. 626, 343–346 (1993).
K. Mori, S. Oka, A. Tani, S. Ito and Y Watanabe: Biochem. Biophys. Res. Commun. 162, 1535–1540 (1989).
G. Siegel, A. Carl, A. Adler and G. Stock: Eicosanoids 2, 213–222 (1989).
W.F. Jackson, A. König, T. Dambacher and R. Busse: Am. J. Physiol. 264, H238–H243 (1993).
S.H. Ferreira and M. Nakamura: Prostaglandins 18, 179–190 (1979).
C.M. Hingtgen, K.J. Waite and M.R. Vasko: J. Neurosci. 15, 5411–5419 (1995).
T.H. Hintze: Fed. Proc. 46, 73–80 (1987).
J. Staszewska-Barczak: Am. J. Cardiol. 52, 36A–45A (1983).
J. Tamaoki, A. Chiyotani, K. Takeyama, E Yamauchi, E. Tagaya and K. Konno: Prostaglandins 45, 363–373 (1993).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Basel AG
About this chapter
Cite this chapter
Wise, H. (1997). Neuronal prostacyclin receptors. In: Jucker, E. (eds) Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, vol 49. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8863-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8863-9_4
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9807-2
Online ISBN: 978-3-0348-8863-9
eBook Packages: Springer Book Archive